Axogen Inc.

NASDAQ:AXGN   3:59:40 PM EDT
19.70
-0.47 (-2.33%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)807.77M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$32.18 Million
Adjusted EPS-$0.13
See more estimates
10-Day MA$19.98
50-Day MA$19.93
200-Day MA$17.31
See more pivots

Axogen Inc. Stock, NASDAQ:AXGN

13631 Progress Boulevard, Suite 400, Alachua, Florida 32615
United States of America
Phone: +1.386.462.6800
Number of Employees: 368

Description

AxoGen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. It also provides products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. The firmâ??s products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator. The company was founded in 1977 and is headquartered in Alachua, FL.